This live streamed event will discuss the increasingly appreciated role of the innate immune system in initiating and directing immune responses.
Oral abstract submission deadline – 10th August 2016
Early registration discount ends – 20th September 2016
Poster submission deadline – 1st November 2016
“Innate Immunity: The first line of defence” has an open abstract session:
Abstracts can be submitted on any subject related to Innate Immunity
Meeting description: The importance of the innate immune system in pathogen recognition is well-established, and it is now becoming clear that early events directed by the innate immune system have substantial and long-lasting effects on the body’s ability to deal with infections successfully. In some cases, inappropriate innate responses can actually impede pathogen and tumour clearance or lead to autoimmune activation. This cross-disciplinary event will discuss recent findings related to the role of the innate immune system in pathogen recognition, effector function and activation of adaptive responses, as well as its importance in aberrant immune function, and will consider the potential of therapeutic targeting of the innate immune system to improve health outcomes.
Who Should Attend: This event is aimed at those interested in the role of the innate immune system in health and disease, and in therapeutic strategies to modulate the innate immune response, including research scientists and academics, physicians and clinicians, and those who work within the industry.
The event will be recorded and available for all registered delegates up to a month after the event. So if you can’t manage all the days, or the different time zones, you can still have access to the full event.
Invited speakers and their talks Include
|Structural Basis of Cell Surface Positioning and Activation of Macrophage-secreted Metalloproteases||Professor Steven R. Van Doren||University of Missouri||United States|
|Investigating the role of STIM1-mediated calcium signalling and ER-membrane contact sites in dendritic cell biology||Dr. Paula Nunes||University of Geneva||Switzerland|
|The value of BCG and innate immunity in autoimmune diseases||Dr. Denise L Faustman||Massachusetts General Hospital||United States|
|A helminth-derived suppressor of IL-33||Dr. Henry McSorley||University of Edinburgh||Unted Kingdom|
|Inflammasome activation in non-immune cells – not just a cytokine story||Dr. Melanie Scott||University of Pittsburgh||United States|
|The role of the human DEAD-box protein DDX3 in innate immunity||Dr Martina Schroeder||National University of Ireland Maynooth||Ireland|
|Influence of the tumor suppressor p53 on human innate immune responses||Dr. Daniel Menendez||National Institute of Environmental Health Sciences (NIEHS)||United States|
|Peptidoglycan and You: Perfect Together?||Dr Catherine Leimkuhler Grimes||University of Delaware||United States|
|Innate lymphoid cell defence||Dr Rebecca Ingram||Queen's University Belfast||United Kingdom|
|The Inflammasome and Intestinal Homeostasis||Dr. Hasan Zaki||UT Southwestern Medical Center||United States|
|Impact of microbiota on ocular immunity||Professor Mihaela Gadjeva||Brigham and Women's Hospital||United States|
|Innate immune responses to pathogenic mycobacteria||Dr. Antje Blumenthal||The University of Queensland Diamantina Institute||Australia|
|Molecular dynamics insights into NOD1-RIP2 interaction||Mr. Jitendra Maharana||Orissa University of Agriculture and Technology||India|
Advisory Board Members
|Professor Áine McKnight||Queen Mary University of London Blizard Institute||United Kingdom|
|Professor Alison M McDermott||University of Houston||United States|
|Dr Tom Monie||University of Cambridge||United Kingdom|
|Dr. Igor Malyshev||Moscow State University of Medicine and Dentistry||Russian Federation|
|Credits from The Institute of Biomedical Science (code)||Approved by the Royal Society of Biology for purposes of CPD|
|TBC||This event may be counted as 54 CPD credits|